Hikma appoints former Fresenius executive as new CSO

Hikma appoints former Fresenius executive as new CSO

11:28 AM, 16th January 2018
Hikma logo

LONDON, UK: Hikma Pharmaceuticals PLC has appointed Surendera Tyagi, PhD, as chief scientific officer (CSO) and global head of research and development. Dr Tyagi will focus on the group’s non-injectables business during the first year and will become a member of Hikma’s executive committee. 

Tyagi joins from Fresenius Kabi, where he most recently led their US innovation & development center. While at Fresenius, he successfully expanded the company’s oncology business. Prior to that, Tyagi served as chief scientific officer for Dabur Pharma, an oncology company that was acquired by Fresenius in 2008. He also has held scientific and/or regulatory roles at Roche, IGEN, Abbott/Hospira, and Schwarz Pharma with increasing management responsibilities.

Dr Tyagi has been an active member of the Association for Affordable Medicines, and participated in GDUFA II negotiations with the FDA.

“Surendera is an outstanding scientist with a proven track record of leading research and development in some of the world’s largest and most successful pharmaceutical organizations,” said Said Darwazah, chairman and CEO, Hikma.

“Research and Innovation is one of our five pillars for growth and the appointment of Surendera is a significant step forward in executing on this strategy.  We are very excited for Surendera to be joining us and accelerating our ability to develop novel ways to improve the health of people around the world,” added Darwazah.

“I am delighted to be joining Hikma at this exciting time in the company’s journey, leading such an important function. Hikma’s track record of delivering affordable, quality medicines to people who need them is a purpose that I share. I look forward to accelerating their R&D efforts by advancing and expanding their pipeline, leveraging Hikma’s highly experienced and talented R&D team,” said Dr Tyagi. 

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Shell finalizes to redevelop Penguins field in UK North Sea

THE HAGUE, NETHERLANDS: Royal Dutch Shell plc (Shell) announced a final investment decision on the redevelopment of the Penguins oil and gas field in ...

Read more
Lanxess presents leather trends for spring-summer 2019

COLOGNE, GERMANY: Lanxess AG has unveiled new leather trends for the spring-summer season 2019. The collection presents tanneries with numerous leathe ...

Read more
Sika acquires majority stake in Italy-based waterproofing company

BAAR, SWITZERLAND: Sika AG has acquired a majority stake in Index Construction Systems and Products (Index), a leading manufacturer of roofing and wat ...

Read more
Total buys Petrobras stake in two Brazilian fields for $1.9 bn

RIO DE JANEIRO, BRAZIL: Petrobras and Total SA have finalized a decisive milestone in the realization of their strategic alliance, with the completion ...

Read more
ExxonMobil finds hydrocarbon reservoirs onshore Papua New Guinea

IRVING, US: ExxonMobil Corporation (XOM) said that it came across hydrocarbons after drilling the onshore P’nyang South-2 well, located in the W ...

Read more
Indorama, Huvis to form low melting fibre JV in US

BANGKOK, THAILAND: Indorama Ventures Public Company Limited (IVL) and Huvis Corporation (HC) announced their intention to establish a 50:50 joint vent ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X